Form 4: Wave Life Sciences Director Receives Stock Grant
Insider Transaction (Form 4)
Mark Corrigan, a Director of Wave Life Sciences Ltd., reported multiple transactions in common stock on October 5, 2026.
Summary
- Grant/award: acquired 10,700 Common Stock on October 5, 2026; holds 39,515 after (Direct).
- Grant/award: acquired 64,000 Stock Option (right to buy) on October 5, 2026; holds 64,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Mark Corrigan — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-05 | Grant/award | Common Stock | 10,700 | — | — | 39,515 |
| 2026-10-05 | Grant/award | Stock Option (right to buy) | 64,000 | — | — | 64,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-05 | Grant/award (10,700 shares) |
| 2026-10-05 | Grant/award (64,000 shares) |
Keywords
insider transaction, Form 4, WVE, Wave Life Sciences, Inc., neutral, Mark Corrigan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.